anti-microbial resistence logo

The leading conference on anti-microbial resistance

Thursday, October 25 - Friday, October 26, 2018
Washington, D.C.

SIGN UP FOR EVENT UPDATES

2018 Top Speakers
 

 

dan wechsler

larry kerr

Paul Auwaerter

Dan Wechsler
President & CEO
Melinta Therapeutics

Larry Kerr
Director, Office of Pandemic and Emerging Threats
U.S. Department of Health and Human Services   
Co-Chair
TATFAR

Paul Auwaerter   
President
Infectious Diseases Society of America (IDSA)

silas holland

christine ardal

WORLD HEALTH ORGANIZATION

Silas Holland 
Director of Infectious Disease Policy
Merck

Christine Ardal 
Senior Advisor
Norwegian Institute of Public Health   
Co-Lead
Drive-AB

Dr. Tedros Adhanom Ghebreyesus  
Director-General
World Health Organization (WHO)
*delivering pre-recorded video message
 

 

150+ SPEAKERS

 

  • Debra Goff at World Anti-Microbial Resistance Congress 2018
    Debra Goff
    Infectious Diseases Specialist,The Ohio State University Wexner Medical Center Clinical Associate Pr
    Ohio State University Medical Center
    Peter Jackson at World Anti-Microbial Resistance Congress 2018
    Peter Jackson
    CEO
    The AMR Centre UK
  • Daniel Knecht at World Anti-Microbial Resistance Congress 2018
    Daniel Knecht
    Vice President, Clinical Strategy & Policy
    Aetna
    Blake Wise at World Anti-Microbial Resistance Congress 2018
    Blake Wise
    Chief Executive Officer
    Achaogen
  • Jeremy Knox at World Anti-Microbial Resistance Congress 2018
    Jeremy Knox
    Policy and Advocacy Lead, Drug-Resistant Infections Programme
    Wellcome Trust
    Jeff Stein at World Anti-Microbial Resistance Congress 2018
    Jeff Stein
    President and Chief Executive Officer
    Cidara Therapeutics
  • Nicholas Adomakoh at World Anti-Microbial Resistance Congress 2018
    Nicholas Adomakoh
    Global Medical Affairs Lead for Anti-infectives
    Sandoz International GmbH
    Christine Årdal at World Anti-Microbial Resistance Congress 2018
    Christine Årdal
    Senior Advisor
    Norwegian Institute of Public Health
  • Thierry Bernardi at World Anti-Microbial Resistance Congress 2018
    Thierry Bernardi
    CEO
    Biofilm Pharma
    Gabrielle Breugelmans at World Anti-Microbial Resistance Congress 2018
    Gabrielle Breugelmans
    Director of Research
    Access to Medicine Foundation
  • Cornelius J. (Neil) Clancy at World Anti-Microbial Resistance Congress 2018
    Cornelius J. (Neil) Clancy
    Associate Professor of Medicine, Infectious Diseases Division, and Director, Mycology Program
    University of Pittsburgh
    Mark Engel at World Anti-Microbial Resistance Congress 2018
    Mark Engel
    CEO
    Phagelux
  • Sandy Estrada at World Anti-Microbial Resistance Congress 2018
    Sandy Estrada
    Director Clinical Affairs
    T2 Biosystems Inc
    Olivier Favre Bulle at World Anti-Microbial Resistance Congress 2018
    Olivier Favre Bulle
    Founder and Consultant in Drug Development and Business Strategy
    3Biotech
  • Kuntal Ganguly at World Anti-Microbial Resistance Congress 2018
    Kuntal Ganguly
    Lead Scientist
    Venus Remedies Limited
    Marc Gitzinger at World Anti-Microbial Resistance Congress 2018
    Marc Gitzinger
    Chief Executive Officer And Co-Founder
    Bioversys
  • Tina Guina at World Anti-Microbial Resistance Congress 2018
    Tina Guina
    CARB-X Program Manager
    BARDA
    Silas Holland at World Anti-Microbial Resistance Congress 2018
    Silas Holland
    Director of Infectious Disease Policy
    Merck & Co
  • Dmitri Iarikov at World Anti-Microbial Resistance Congress 2018
    Dmitri Iarikov
    Deputy Director in the Division of Anti-Infective Products
    FDA
    Amanda Jezek at World Anti-Microbial Resistance Congress 2018
    Amanda Jezek
    Senior VP, Public Policy and Government Relations
    Infectious Diseases Society of America
  • Wes Kim at World Anti-Microbial Resistance Congress 2018
    Wes Kim
    Senior Officer
    The Pew Charitable Trusts
    John Kokai-Kun at World Anti-Microbial Resistance Congress 2018
    John Kokai-Kun
    Vice President of Non-Clinical Affairs
    Synthetic Biologics Inc
  • Colm Leonard at World Anti-Microbial Resistance Congress 2018
    Colm Leonard
    Consultant Clinical Advisor
    NICE
    Tom Lowery at World Anti-Microbial Resistance Congress 2018
    Tom Lowery
    Chief Scientific Officer
    T2 Biosystems Inc
  • Gregory Mario at World Anti-Microbial Resistance Congress 2018
    Gregory Mario
    Chief Executive Officer
    T.A.X.I.S. Pharmaceuticals Inc
    Pascal Mayer at World Anti-Microbial Resistance Congress 2018
    Pascal Mayer
    Chief Executive Officer
    Alphanosos
  • Mary Millard at World Anti-Microbial Resistance Congress 2018
    Mary Millard
    M. Ed, Patient Advocate
    Sepsis Survivor
    Donald Moir at World Anti-Microbial Resistance Congress 2018
    Donald Moir
    Chief Scientific Officer
    Microbiotix Inc
  • Steve Nagler at World Anti-Microbial Resistance Congress 2018
    Steve Nagler
    Executive Director
    MedPro Investors LLC
    Kevin Outterson at World Anti-Microbial Resistance Congress 2018
    Kevin Outterson
    Executive Director
    CARB-X
  • Jean-Pierre Paccaud at World Anti-Microbial Resistance Congress 2018
    Jean-Pierre Paccaud
    Director, Business Development and Corporate Strategy
    Global Antibiotic Research and Development Partnership (GARDP)
    Marie Petit at World Anti-Microbial Resistance Congress 2018
    Marie Petit
    Coordinator
    The Beam Alliance
  • Harshika Sarbajna at World Anti-Microbial Resistance Congress 2018
    Harshika Sarbajna
    Global Head, Anti-infectives
    Sandoz International GmbH
    Ted Schroeder at World Anti-Microbial Resistance Congress 2018
    Ted Schroeder
    Chief Executive Officer
    Nabriva Therapeutics
  • Rajeev Sehgal at World Anti-Microbial Resistance Congress 2018
    Rajeev Sehgal
    Director of Informatics
    Becton Dickinson
    Keiko Tone at World Anti-Microbial Resistance Congress 2018
    Keiko Tone
    VP Market Access
    Shionogi Limited
  • Fred Turner at World Anti-Microbial Resistance Congress 2018
    Fred Turner
    Founder & CEO
    Shield Diagnostics
    Evan Tzanis at World Anti-Microbial Resistance Congress 2018
    Evan Tzanis
    Senior Vice President, Chief Development Officer
    Paratek Pharmaceuticals
  • Nick Van Hise at World Anti-Microbial Resistance Congress 2018
    Nick Van Hise
    Infectious Diseases Clinical Pharmacy Specialist, Research Coordinator
    Metro Infectious Disease Consultants
    Richard Vickers at World Anti-Microbial Resistance Congress 2018
    Richard Vickers
    SVP and CSO, Anti-Infectives
    Summit Therapeutics
  • Susan Casey Bleasdale at World Anti-Microbial Resistance Congress 2018
    Susan Casey Bleasdale
    Medical Director Infection Prevention & Control and Antimicrobial Stewardship
    University of Illinois Hospital & Health Sciences System
    Mark Bradley at World Anti-Microbial Resistance Congress 2018
    Mark Bradley
    Director
    EPSRC Proteus IRC
  • Lisa Davidson at World Anti-Microbial Resistance Congress 2018
    Lisa Davidson
    Medical Director, Antimicrobial Support Network
    Atrium Health
    Barry Eisenstein at World Anti-Microbial Resistance Congress 2018
    Barry Eisenstein
    Chair, Scientific Advisory Board
    CARB-X
  • Greg Frank at World Anti-Microbial Resistance Congress 2018
    Greg Frank
    Director, Infectious Disease Policy
    BIO
    Elizabeth Hermsen at World Anti-Microbial Resistance Congress 2018
    Elizabeth Hermsen
    Head, Global Antimicrobial Stewardship
    Merck & Co., Inc.
  • Chris Houchens at World Anti-Microbial Resistance Congress 2018
    Chris Houchens
    Health Scientist
    BARDA
    Mark Jones at World Anti-Microbial Resistance Congress 2018
    Mark Jones
    Head of Clinical Development and Preclinical Development
    Basilea Pharmaceutica Ltd
  • Patrick Keenan at World Anti-Microbial Resistance Congress 2018
    Patrick Keenan
    Managing Director
    Prevail Partners
    Larry Kerr at World Anti-Microbial Resistance Congress 2018
    Larry Kerr
    Director, Office of Pandemic and Emerging Threats, Office of Global Affairs
    Department of Health and Human Services
  • Eili Klein at World Anti-Microbial Resistance Congress 2018
    Eili Klein
    Fellow
    Center for Disease Dynamics Economics & Policy
    Jane Knisely at World Anti-Microbial Resistance Congress 2018
    Jane Knisely
    Program Officer, Bacteriology and Mycology Branch
    NIAID, NIH
  • Jill Massey at World Anti-Microbial Resistance Congress 2018
    Jill Massey
    Senior Vice President, Medical Affairs
    Melinta Therapeutics Inc
    Mary Motyl at World Anti-Microbial Resistance Congress 2018
    Mary Motyl
    Director of Clinical Microbiology
    Merck & Co
  • Manos Perros at World Anti-Microbial Resistance Congress 2018
    Manos Perros
    President & CEO
    Entasis Therapeutics
    Yannick Pletan at World Anti-Microbial Resistance Congress 2018
    Yannick Pletan
    Acting Chief Medical Officer
    Biofilm Pharma
  • Michael Salter at World Anti-Microbial Resistance Congress 2018
    Michael Salter
    R&D Facilitator
    A.B. Agri
    Robert Sambursky at World Anti-Microbial Resistance Congress 2018
    Robert Sambursky
    President and Chief Executive Officer
    Rapid Pathogen Screening, Inc (RPS)
  • Monika Schneider at World Anti-Microbial Resistance Congress 2018
    Monika Schneider
    Research Associate, Margolis Center for Health Policy
    Duke University
    Ed Septimus at World Anti-Microbial Resistance Congress 2018
    Ed Septimus
    Medical Director of Infection Prevention and Epidemiology
    H.C.A.
  • Ribhi Shawar at World Anti-Microbial Resistance Congress 2018
    Ribhi Shawar
    Branch Chief, Division of Microbiology
    CDRH OIVD FDA
    Rick Sibbel at World Anti-Microbial Resistance Congress 2018
    Rick Sibbel
    Executive Director and Technical Services
    Merck Animal Health
  • Jennifer Townsend at World Anti-Microbial Resistance Congress 2018
    Jennifer Townsend
    Director of Antimicrobial Stewardship program
    Johns Hopkins Bayview Medical Center
    Brian Tse at World Anti-Microbial Resistance Congress 2018
    Brian Tse
    Health Scientist
    HHS/BARDA
  • Daniel Wechsler at World Anti-Microbial Resistance Congress 2018
    Daniel Wechsler
    Chief Executive Officer
    Melinta Therapeutics Inc
    Zachary Zimmerman at World Anti-Microbial Resistance Congress 2018
    Zachary Zimmerman
    CEO
    Forge Therapeutics
  • Dirar Abdullah at World Anti-Microbial Resistance Congress 2018
    Dirar Abdullah
    Head, Adult Critical Care Services, Chair, Antibiotic Committee and Antibiotic Stewardship Program
    Prime Hospital- Dubai
    Brian Michael Aldridge at World Anti-Microbial Resistance Congress 2018
    Brian Michael Aldridge
    Clinical Professor, Department of Veterinary Clinical Medicine
    University of Illinois College of Veterinary Medicine
  • Timothy Cooke at World Anti-Microbial Resistance Congress 2018
    Timothy Cooke
    Chief Executive Officer
    NovaDigm Therapeutics
    Glenn Dale at World Anti-Microbial Resistance Congress 2018
    Glenn Dale
    Head of Early Development, Antimicrobials
    Polyphor Ltd
  • Gregory Daniel at World Anti-Microbial Resistance Congress 2018
    Gregory Daniel
    Deputy Director
    Duke University
    Sarah Doernberg at World Anti-Microbial Resistance Congress 2018
    Sarah Doernberg
    Associate Professor
    University of California, San Francisco
  • Eugean Jiwanmall at World Anti-Microbial Resistance Congress 2018
    Eugean Jiwanmall
    Senior Research Analyst, Technology Evaluation & Medical Policy
    Independence Blue Cross
    Lee Jones at World Anti-Microbial Resistance Congress 2018
    Lee Jones
    Founder, President and Chief Executive Officer
    Rebiotix, Inc.
  • Kerry Laplante at World Anti-Microbial Resistance Congress 2018
    Kerry Laplante
    Professor
    University Of Rhode Island
    Brandon Palermo at World Anti-Microbial Resistance Congress 2018
    Brandon Palermo
    CMO at ILUM Health Solutions and Executive Director and CMO
    Merck & Co
  • Rangarajan Sampath at World Anti-Microbial Resistance Congress 2018
    Rangarajan Sampath
    Chief Scientific Officer
    FIND
    Henry Skinner at World Anti-Microbial Resistance Congress 2018
    Henry Skinner
    Senior Vice President
    Tekla Capital Management
  • Leslie Tari at World Anti-Microbial Resistance Congress 2018
    Leslie Tari
    Vice President, Discovery
    Cidara Therapeutics
    Ephraim Tsalik at World Anti-Microbial Resistance Congress 2018
    Ephraim Tsalik
    Associate Professor of Medicine Division of Infectious Diseases
    Duke University Medical Center
  • Javad Aman at World Anti-Microbial Resistance Congress 2018
    Javad Aman
    Chief Executive Officer
    Integrated Biotherapeutics
    Sanjeet Dadwal at World Anti-Microbial Resistance Congress 2018
    Sanjeet Dadwal
    Associate Clinical Professor Head of Antimicrobial Stewardship Program
    City of Hope
  • Steven Gilman at World Anti-Microbial Resistance Congress 2018
    Steven Gilman
    Chief Executive Officer
    Contrafect Corporation
    Rana Hamdy at World Anti-Microbial Resistance Congress 2018
    Rana Hamdy
    Director, Antimicrobial Stewardship Program
    Children's National Health System
  • Benjamin Hammer at World Anti-Microbial Resistance Congress 2018
    Benjamin Hammer
    Co-leader of the Antimicrobial Stewardship Program
    Children's National Health System
    David Huang at World Anti-Microbial Resistance Congress 2018
    David Huang
    Chief Medical Officer
    Motif Bio
  • Trish Simner at World Anti-Microbial Resistance Congress 2018
    Trish Simner
    Director of Bacteriology and Parasitology, Division of Medical Microbiology
    Johns Hopkins Medical Institutions

 

View 150+ Speakers

2018 CONFIRMED ATTENDEES  
 

amr attendees
amr attendees
amr attendees
amr attendees

amr attendees
amr attendees
amr attendees
AMR congress attendees

                                                      
"Very well organized. Perfect number of attendees and the right mix of policy makers, industry, scientists and clinicians. Enables free flow of ideas and actionable items."

-- Kartikeya Cherabuddi, Director of Antimicrobial Stewardship and Infectious Diseases, Medical Specialties, University of Florida College of Medicine

 

 

 

 

REGISTER NOW

 Sponsors

 

Platinum Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Silver Sponsor

Silver Sponsor

Associate

Associate

Associate

Associate

Associate

Rapid Pathogen Screening, Inc (RPS) at World Anti-Microbial Resistance Congress 2018

Associate

Associate

 

 

DOWNLOAD SPONSORSHIP BROCHURE

Learn more about the only commercial conference on antimicrobial resistance

Our program and audience revolves around advancing antibiotic & diagnostics development, improving antimicrobial stewardship programs and practice and solving the funding and partnering challenges in infectious diseases R&D to curb AMR. 

We are also the largest AMR focused event, with over 150 speakers and 400 attendees from over 20 countries.

If your organization is working to curb Anti-Microbial Resistance then you must attend the World AMR Congress 2018!

 

DOWNLOAD BROCHURE

Venue

Ritz-Carlton
1150 22nd Street NW
Washington, DC 20037
+1 202 835 0500

Conference times

October 25, 2018
Registration: 8:00am - 9:00am
Conference: 8:50am - 6:00pm
Cocktail Hour: 6:00pm - 7:00pm
October 26, 2018
Registration: 8:00am - 9:00am 
Conference
: 8:50am - 3:50pm